🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
COVID-19 morbidity and mortality has been associated with Cytokine Release ...
Status
Completed
Location
The University of Kansas Medical Center
Start Date
2020-07-20
Trial ID
NCT04481685
This is a Phase 2a study to investigate the efficacy, safety, tolerability,...
Status
Completed
Location
Aclaris Investigational Site
Start Date
2021-12-29
Trial ID
NCT05216224
Treatments Being Tested
The investigators hypothesize that MK2 inhibition may improve efficacy of m...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2025-06-13
Trial ID
NCT06648434
Treatments Being Tested
This study evaluates ATI-450 plus MTX versus placebo plus MTX in participan...
Status
Completed
Location
Aclaris Investigational Site
Start Date
2022-02-01
Trial ID
NCT05279417
Treatments Being Tested
This is a Phase 2a study to investigate the efficacy, safety, tolerability,...
Status
Terminated
Location
Aclaris Investigational Site
Start Date
2022-07-12
Trial ID
NCT05511519
Treatments Being Tested
This is a Phase 2 study to investigate the safety and efficacy of ATI-450 f...
Status
Terminated
Location
Aclaris Investigational Site
Start Date
2020-10-23
Trial ID
NCT04524858
Treatments Being Tested
This is a Phase 2 study to investigate the safety, tolerability, PK, and PD...
Status
Completed
Location
Aclaris Investigational Site
Start Date
2020-03-16
Trial ID
NCT04247815
Treatments Being Tested
This is a phase Ib/II study evaluating the safety and efficacy of zunsemeti...
Status
Recruiting
Location
The University of Kansas Cancer Center
Start Date
2025-01-30
Trial ID
NCT06374459
Treatments Being Tested